These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 5473147)

  • 1. Enhancement of imipramine by thyroid stimulating hormone: clinical and theoretical implications.
    Prange AJ; Wilson IC; Knox A; McClane TK; Lipton MA
    Am J Psychiatry; 1970 Aug; 127(2):191-9. PubMed ID: 5473147
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhancement of imipramine antidepressant activity by thyroid hormone.
    Prange AJ; Wilson IC; Rabon AM; Lipton MA
    Am J Psychiatry; 1969 Oct; 126(4):457-69. PubMed ID: 4185164
    [No Abstract]   [Full Text] [Related]  

  • 3. Thyroid-hormone enhancement of imipramine in nonretarded depressions.
    Wilson IC; Prange AJ; McClane TK; Rabon AM; Lipton MA
    N Engl J Med; 1970 May; 282(19):1063-7. PubMed ID: 4908885
    [No Abstract]   [Full Text] [Related]  

  • 4. Hormonal potentiation of imipramine and ECT in primary depression.
    Feighner JP; King LJ; Schuckit MA; Croughan J; Briscoe W
    Am J Psychiatry; 1972 Apr; 128(10):1230-8. PubMed ID: 4552204
    [No Abstract]   [Full Text] [Related]  

  • 5. Thyroid-imipramine clinical and chemical interaction: evidence for a receptor deficit in depression.
    Prange AJ; Wilson IC; Knox AE; McClane TK; Breese GR; Martin BR; Alltop LB; Lipton MA
    J Psychiatr Res; 1972 Sep; 9(3):187-205. PubMed ID: 5083174
    [No Abstract]   [Full Text] [Related]  

  • 6. The comparative antidepressant value of L-tryptophan and imipramine with and without attempted potentiation by liothyronine.
    Coppen A; Whybrow PC; Noguera R; Maggs R; Prange AJ
    Arch Gen Psychiatry; 1972 Mar; 26(3):234-41. PubMed ID: 4551048
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of imipramine-resistant recurrent depression: I. An open clinical trial of adjunctive L-triiodothyronine.
    Thase ME; Kupfer DJ; Jarrett DB
    J Clin Psychiatry; 1989 Oct; 50(10):385-8. PubMed ID: 2676995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of amitriptyline by thyroid hormone.
    Wheatley D
    Arch Gen Psychiatry; 1972 Mar; 26(3):229-33. PubMed ID: 4551047
    [No Abstract]   [Full Text] [Related]  

  • 9. Thyroid hormone in the treatment of depression.
    Slusher N
    South Med J; 1975 Aug; 68(8):1035-6. PubMed ID: 808858
    [No Abstract]   [Full Text] [Related]  

  • 10. A controlled study of single-dose administration of imipramine pamoate in endogenous depression.
    Miller WC; Marcotte DB; McCurdy L
    Curr Ther Res Clin Exp; 1973 Oct; 15(10):700-6. PubMed ID: 4201314
    [No Abstract]   [Full Text] [Related]  

  • 11. The possible role of thyroid and thyrotrophic hormones in depressive illness.
    Mountjoy CQ
    Postgrad Med J; 1976; 52(3 suppl):103-9. PubMed ID: 822406
    [No Abstract]   [Full Text] [Related]  

  • 12. Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature.
    Altshuler LL; Bauer M; Frye MA; Gitlin MJ; Mintz J; Szuba MP; Leight KL; Whybrow PC
    Am J Psychiatry; 2001 Oct; 158(10):1617-22. PubMed ID: 11578993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of antidepressant effects by L-triiodothyronine in tricyclic nonresponders.
    Goodwin FK; Prange AJ; Post RM; Muscettola G; Lipton MA
    Am J Psychiatry; 1982 Jan; 139(1):34-8. PubMed ID: 7055275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid function and the response to liothyronine in depression.
    Whybrow PC; Coppen A; Prange AJ; Noguera R; Bailey JE
    Arch Gen Psychiatry; 1972 Mar; 26(3):242-5. PubMed ID: 4551049
    [No Abstract]   [Full Text] [Related]  

  • 15. The electroencephalographic and psychological effects of imipramine in depressed inpatients.
    Bhanji S; Lader M
    Eur J Clin Pharmacol; 1977 Dec; 12(5):349-54. PubMed ID: 598406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myxedematous madness without myxedema. Selective defect of TSH release on TRF loading in a young woman with a history of severe depressive illness cured with thryoid hormone replacement therapy.
    Nordgren L; von Schéele C
    Acta Med Scand; 1976; 199(3):233-6. PubMed ID: 816176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring the pharmacological action of imipramine in the treatment of depressions.
    Rosenblatt S; Chanley JD
    Arch Gen Psychiatry; 1974 Apr; 30(4):456-60. PubMed ID: 4815551
    [No Abstract]   [Full Text] [Related]  

  • 18. [A case of generalized tissue resistance to thyroid hormones].
    Lakatos P; Földes J; Bános C
    Orv Hetil; 1986 Mar; 127(10):583-6. PubMed ID: 3085046
    [No Abstract]   [Full Text] [Related]  

  • 19. Double blind clinical study comparing doxepin and imipramine in depression.
    Hasan KZ; Akhtar MI
    Curr Ther Res Clin Exp; 1971 Jun; 13(6):327-36. PubMed ID: 4996218
    [No Abstract]   [Full Text] [Related]  

  • 20. Triiodothyronine, imipramine, and depression.
    Steiner M
    Am J Psychiatry; 1980 Mar; 137(3):383-4. PubMed ID: 7356079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.